FDA, Industry Assess Best Way To Communicate Risk in DTC Ads
Executive Summary
ATLANTA - When designing direct-to-consumer television ads, FDA would "prefer that you have the major risks in the audio," Amie O'Donoghue of FDA's Division of Drug Marketing, Advertising and Communications advised industry at the Drug Information Association annual meeting June 19
You may also be interested in...
Rx TV Ads To Get FDA Study On How Visual Cues May Distract From Audio Risks
Data collection in an FDA study of how the audio, visual and textual components of a television ad affect a viewer's intake of information and perception of a drug's risks and benefits is expected to begin in May 2008
Rx TV Ads To Get FDA Study On How Visual Cues May Distract From Audio Risks
Data collection in an FDA study of how the audio, visual and textual components of a television ad affect a viewer's intake of information and perception of a drug's risks and benefits is expected to begin in May 2008
Risk Disclosure In Drug Ads Will Be FDA’s Focus After House Defeats DTC Ban
The revised language on direct-to-consumer advertising in the FDA safety bills pending in Congress no longer allows the agency to ban ads, but creates a number of new disclosure requirements for the spots